Cargando…

Coxsackievirus B3—Its Potential as an Oncolytic Virus

Oncolytic virotherapy represents one of the most advanced strategies to treat otherwise untreatable types of cancer. Despite encouraging developments in recent years, the limited fraction of patients responding to therapy has demonstrated the need to search for new suitable viruses. Coxsackievirus B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geisler, Anja, Hazini, Ahmet, Heimann, Lisanne, Kurreck, Jens, Fechner, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143167/ https://www.ncbi.nlm.nih.gov/pubmed/33919076 http://dx.doi.org/10.3390/v13050718

Ejemplares similares

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
por: Hazini, Ahmet, et al.
Publicado: (2021)

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011)

Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021)

Tackling HLA Deficiencies Head on with Oncolytic Viruses
por: Fisher, Kerry, et al.
Publicado: (2021)

Inhibition of coxsackievirus B3 by RNA interference (RNAi)
por: Kurreck, J, et al.
Publicado: (2006)

Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
por: Liu, Huitao, et al.
Publicado: (2021)

Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
por: Deng, Haoyu, et al.
Publicado: (2019)

Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3
por: Liu, Huitao, et al.
Publicado: (2022)

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor
por: Fechner, H, et al.
Publicado: (2007)

Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
por: Lin, Yanzhen, et al.
Publicado: (2018)

Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
por: Geisler, Anja, et al.
Publicado: (2023)

MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer
por: Liu, Huitao, et al.
Publicado: (2020)

MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer
por: Liu, Huitao, et al.
Publicado: (2021)

SEC coupled with in-line multiple detectors for the characterization of an oncolytic Coxsackievirus
por: Deng, James Z., et al.
Publicado: (2021)

2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus
por: Vorobyev, Pavel O., et al.
Publicado: (2022)

Deregulation of HLA-I in cancer and its central importance for immunotherapy
por: Hazini, Ahmet, et al.
Publicado: (2021)

Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3
por: Jia, Yang, et al.
Publicado: (2019)

Coxsackievirus Group B3 Has Oncolytic Activity against Colon Cancer through Gasdermin E-Mediated Pyroptosis
por: Zhang, Yejia, et al.
Publicado: (2022)

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy
por: Burnett, William J., et al.
Publicado: (2021)

Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
por: Okamura, Koji, et al.
Publicado: (2022)

Theranostic Potential of Oncolytic Vaccinia Virus
por: Rojas, Juan J, et al.
Publicado: (2012)

A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca(2+) Uptake into the Sarcoplasmic Reticulum
por: Größl, Tobias, et al.
Publicado: (2014)

Potential of oncolytic viruses in the treatment of multiple myeloma
por: Bartee, Eric
Publicado: (2018)

Vaccines against Group B Coxsackieviruses and Their Importance
por: Mone, Kiruthiga, et al.
Publicado: (2023)

Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer
por: Sakamoto, Akira, et al.
Publicado: (2023)

Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome
por: Sam, Miranda, et al.
Publicado: (2023)

Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
por: Annels, Nicola E, et al.
Publicado: (2015)

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
por: Kemp, Vera, et al.
Publicado: (2015)

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters
por: Schaar, Katrin, et al.
Publicado: (2017)

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
por: Hamid, Omid, et al.
Publicado: (2017)

Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses
por: Matveeva, Olga V., et al.
Publicado: (2018)

Oncolytic Viruses as Anticancer Vaccines
por: Woller, Norman, et al.
Publicado: (2014)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
por: Si, Xiaoning, et al.
Publicado: (2008)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

Simulating coxsackievirus B3 infection with an accessible computational model of its complete kinetics
por: Griffiths, Cameron D., et al.
Publicado: (2021)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Designing and building oncolytic viruses
por: Maroun, Justin, et al.
Publicado: (2017)

Tumor Restrictions to Oncolytic Virus
por: Vähä-Koskela, Markus, et al.
Publicado: (2014)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g2s8hldfpsiflvte09gk4qc78k